뉴스/Reuters/CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code For Conexxence And BomyntraCMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code For Conexxence And BomyntraRefinitiv1분 미만 읽기Fresenius Kabi Oncology Ltd (FRES.M3):CMS GRANTS FRESENIUS KABI PERMANENT, PRODUCT-SPECIFIC Q-CODE FOR CONEXXENCE® AND BOMYNTRA® (DENOSUMAB-BNHT)Reuters아시아© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html더 보기이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오렛츠고
